| abstract |
In certain embodiments, the present invention provides a composition comprising a cell-reactive compstatin analog and a cell-reactive compstatin analog. In certain embodiments, the invention further provides methods of using cell-reactive compstatin analogs, eg, treatment of complement-mediated disorders, eg, to inhibit complement-mediated damage to cells, tissues or organs. . In certain embodiments, the present invention provides a composition comprising a long-acting compstatin analog and a long-acting compstatin analog. In certain embodiments, the invention further provides for the use of a long-acting compstatin analog, eg, to inhibit complement-mediated damage to a cell, tissue, or organ, eg, to treat a complement-mediated disorder. Provide a method. In certain embodiments, the present invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In certain embodiments, the present invention further provides methods of using targeted compstatin analogs, eg, to inhibit complement-mediated damage to cells, tissues, or organs, eg, to treat complement-mediated disorders. provide. |